Taclonex Side Effects

Generic Name: betamethasone / calcipotriene topical

Note: This page contains side effects data for the generic drug betamethasone / calcipotriene topical. It is possible that some of the dosage forms included below may not apply to the brand name Taclonex.

It is possible that some side effects of Taclonex may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

For the Consumer

Applies to betamethasone / calcipotriene topical: topical application ointment, topical application suspension

As well as its needed effects, betamethasone / calcipotriene topical may cause unwanted side effects that require medical attention.

If any of the following side effects occur while taking betamethasone / calcipotriene topical, check with your doctor immediately:

Less common
  • Burning, itching, and pain in hairy areas
  • burning sensation of the skin
  • flushing or redness of the skin
  • itching skin
  • pus at the root of the hair
  • red, scaling, or crusted skin
  • scaly rash
  • skin irritation
  • thinning of the skin with easy bruising
  • unusually warm skin
Rare
  • Body aches or pain
  • chills
  • cough
  • darkening of the skin
  • diarrhea
  • difficulty in breathing
  • ear congestion
  • fever
  • general feeling of discomfort or illness
  • headache
  • joint pain
  • lightening of normal skin color
  • lightening of the treated areas of dark skin
  • loss of appetite
  • loss of voice
  • muscle aches and pains
  • nasal congestion
  • nausea
  • raised, dark red, or wart-like spots on skin
  • red, sore eyes
  • runny nose
  • shivering
  • sneezing
  • sore throat
  • spots on your skin that look like a blister or pimple
  • sweating
  • trouble sleeping
  • unusual tiredness or weakness
  • vomiting
  • worsening of the psoriasis

Some betamethasone / calcipotriene topical side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

Less common
  • Bruising
  • large, flat, blue, or purplish patches in the skin
  • pain
Rare
  • Blemishes on the skin
  • pimples

For Healthcare Professionals

Applies to betamethasone / calcipotriene topical: topical ointment, topical suspension

Dermatologic

Common (1% to 10%): Ointment: Pruritus (up to 7.2%), psoriasis (up to 3.4%), skin atrophy (up to 1.9%), folliculitis (up to 1.4%), skin depigmentation (1.4%), scaly rash (1.2%), hand dermatitis (1%); Suspension: Pruritus (3.6%), psoriasis (2.4%), erythema (2.1%), skin irritation (1.4%), folliculitis (up to 1.2%)
Uncommon (0.1% to 1%): Ointment: Erythema (up to 1%), skin irritation (0.4%), papular rash (greater than 0.1% and less than 1%), pustular rash (greater than 0.1% and less than 1%), skin hypopigmentation (greater than 0.1% and less than 1%), telangiectasia (0.1%), skin hyperpigmentation (0.1%); Suspension: Acne (greater than 0.1% and less than 1%), exacerbation of psoriasis (greater than 0.1% and less than 1%), rash (greater than 0.1% and less than 1%), pustular rash (greater than 0.1% and less than 1%)
Rare (less than 0.1%): Ointment: Serious flare-up of psoriasis (at least 1 case)
Postmarketing reports: Ointment: Pustular psoriasis

Nervous system

Common (1% to 10%): Ointment: Headache (2.8%)

Metabolic

Frequency not reported: Hypercalcemia, hypercalciuria

Endocrine

Frequency not reported: Adrenal suppression; Ointment: Hypothalamic-pituitary-adrenal axis suppression

Hypersensitivity

Frequency not reported: Allergic contact dermatitis

Respiratory

Common (1% to 10%): Ointment: Nasopharyngitis (2.3%)
Uncommon (0.1% to 1%): Ointment: Influenza (0.9%), upper respiratory tract infection (0.8%)

Other

Common (1% to 10%): Ointment: Burning sensation (up to 1.4%); Suspension: Burning sensation of skin (1%)
Uncommon (0.1% to 1%): Ointment: Pain (0.3%)
Postmarketing reports: Ointment: Rebound effect

Hematologic

Common (1% to 10%): Ointment: Ecchymosis (1%)

Local

Uncommon (0.1% to 1%): Ointment: Application site pruritus (0.5%)

Ocular

Uncommon (0.1% to 1%): Suspension: Eye irritation (greater than 0.1% and less than 1%)

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web3)